Stormy Chamberlain, Ph.D., is a widely published, 10-year researcher in the field of Angelman syndrome and UBE3A, who has given more than 30 talks and lectures about a variety of related topics. Dr. Chamberlain is currently an assistant professor in the University of Connecticut’s Genetics and Developmental Biology department, and is assistant director for UConn’s Graduate Program in Genetics and Developmental Biology.
Dr. Chamberlain established her own lab at UConn in 2009, using induced pluripotent stem cells (iPSC) to model and study human imprinting disorders, focusing on Angelman syndrome, Prader-Willi syndrome, and Duplication 15q syndrome. Her lab works closely with Dr. Marc Lalande’s lab and currently has two major on-going projects. She is also a frequent collaborator with other high-profile Angelman syndrome researchers. In addition to the ASF Scientific Advisory Committee, Dr. Chamberlain serves on the Dup15q Alliance Scientific Advisory Board and on the International Journal of Medical Genetics Editorial Board. Dr. Chamberlain earned her B.A. in Molecular Biology from Princeton University and her Ph.D. in Molecular Genetics from the University of Florida, and conducted post-doctoral work at the University of North Carolina and UConn Health Center.